drugset / Trial / NCT02973724
EC95 of Remifentanil for Preventing Cough
NaSingle-groupOpen-labelTreatment
Summary
The investigator designed this study to investigate remifentanil effect-site concentration in 95% of patients (EC95) for preventing cough after laryngomicrosurgery from propofol anesthesia.
Timeline
- Start
- 2016-11
- Primary completion
- 2017-06
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remifentanil | Small molecule | 1 ng/ml | — |
| Background | Propofol | Small molecule | 5 ug/ml | — |